Fig. 3From: Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profilingFrequency (a) and proportion (b) of death across PTEN-L breast cancer subgroups. ER, estrogen receptor; PTEN, phosphatase and tensin homologBack to article page